IRESSA cpr pell 250 mg 30 pce

7680561540011 CH-56154 L01EB01 07.16.1.

Reimbursement limitations:

IRESSA2

IRESSA est indiqué chez les adultes dans le traitement du cancer bronchique non à petites …

IRESSA cpr pell 250 mg 30 pce
IRESSA cpr pell 250 mg 30 pce
IRESSA cpr pell 250 mg 30 pce
1 / 3
google

Details

Product number
5615401
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
gefitinibum 250 mg, lactosum monohydricum 163.5 mg, cellulosum microcristallinum, carmellosum natricum conexum, povidonum K 29-32, natrii laurilsulfas, magnesii stearas, Überzug: hypromellosum, macrogolum 300, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto corresp. natrium 2.02 mg.

Articles (1)

Iressa, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/08/2022
Professional SmPC
Français
18/08/2022
Professional SmPC
Italien
18/08/2022
Patient information leaflet
Allemand
13/01/2021
Patient information leaflet
Français
13/01/2021
Patient information leaflet
Italien
13/01/2021

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
163.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
2.02 MG Substance HBESI

Reimbursement information

Public price
CHF 2367.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2011

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
56154
Drug name
Iressa, Filmtabletten
Galenic form
FILM
ATC Code
L01EB01
Authorization status
Z
Dispensation category
A
First authorization
02/03/2004
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Packaging details

Description (FR)
IRESSA cpr pell 250 mg 30 pce
Description (DE)
IRESSA Filmtabl 250 mg 30 Stk
Market launch
02/03/2004
Narcotic (BTM)
No